Charles Cabral is an experienced professional in the biopharmaceutical industry, currently serving as Sr. Director of MSAT at Arcturus Therapeutics since May 2021, where responsibilities include serving as the technical lead for the production of CGMP mRNA drug substances for various phases of clinical and commercial products. Prior roles include Director and Associate Director of Process Development and Engineering at TriLink BioTechnologies, managing tech transfer and process development for cGMP mRNA production, and Associate Director of Process Development at Vical, overseeing large-scale manufacturing transitions. Early career experiences encompass significant roles at Thermo Fisher Scientific and research assistant positions at Cal Poly DPTC. Charles holds a Bachelor of Science in Chemical Engineering from UCLA.
This person is not in any teams
This person is not in any offices